Disease Info Card

Vocal Cord Paralysis

Information about Vocal Cord Paralysis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Vocal Cord Paralysis

Most recent studies have shown that Vocal Cord Paralysis shares some biological mechanisms with airway-obstruction, carcinoma, deglutition-disorders, dyspnea, goiter, hoarseness, laryngeal-diseases, laryngeal-neoplasm, laryngeal-nerve-paralysis, malignant-neoplasms, neoplasms, nerve-paralysis, paralysis-of-larynx, paralysis-unilateral-vocal-cord, paresis, recurrent-laryngeal-nerve-injuries, recurrent-laryngeal-nerve-paralysis, stridor, thyroid-neoplasm, voice-disorders.

Among the many pathways, these few ones have gauged particular interests from scientists studying Vocal Cord Paralysis, and have been seen in publications frequently: Aging, Dehiscence, Gastric Emptying, Granuloma Formation, Hemostasis, Hypersensitivity, Inflammatory Response, Innervation, Localization, Muscle Atrophy, Muscle Contraction, Ossification, Pathogenesis, Peristalsis, Reflex, Regeneration, Secretion, Segmentation, Transport, Transposition

Quite a number of genes have been found to play important roles in Vocal Cord Paralysis, such as C2, CAT, CENPJ, CLTA, CRAT, FLVCR1, GDAP1, GLYAT, GUCY2D, PTH, PTPRC, SLC17A5, SLC25A5, SLN, SOD1, STRAP, TG, TNFSF14, VCP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.